Welcome to LookChem.com Sign In|Join Free
  • or
(9β,10α,23E)-3α,16α,20,25-Tetrahydroxy-9-methyl-19-norlanosta-5,23-diene-2,11,22-trione is a complex chemical compound derived from lanosterol, a triterpenoid that acts as a precursor for steroid biosynthesis. (9β,10α,23E)-3α,16α,20,25-Tetrahydroxy-9-methyl-19-norlanosta-5,23-diene-2,11,22-trione features a unique molecular structure with four hydroxyl groups, a ketone group, and a methyl group at position 9. Although its chemical properties and biological activities are not yet well-documented, its status as a triterpenoid derivative suggests it may hold potential pharmacological benefits, such as anti-inflammatory, antioxidant, or anticancer properties. Further research is necessary to explore and confirm its possible applications and effects.

68422-20-8

Post Buying Request

68422-20-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68422-20-8 Usage

Uses

Used in Pharmaceutical Industry:
(9β,10α,23E)-3α,16α,20,25-Tetrahydroxy-9-methyl-19-norlanosta-5,23-diene-2,11,22-trione is used as a potential therapeutic agent for its possible anti-inflammatory, antioxidant, and anticancer properties. Its triterpenoid origin suggests it may contribute to the development of new drugs targeting various diseases and conditions.
Used in Cosmetic Industry:
As a derivative of lanosterol, (9β,10α,23E)-3α,16α,20,25-Tetrahydroxy-9-methyl-19-norlanosta-5,23-diene-2,11,22-trione may be utilized in the cosmetic industry for its potential skin health benefits, such as anti-aging or moisturizing effects, due to its antioxidant and anti-inflammatory properties.
Used in Research and Development:
(9β,10α,23E)-3α,16α,20,25-Tetrahydroxy-9-methyl-19-norlanosta-5,23-diene-2,11,22-trione is used as a subject of study in the field of chemical and biological research to better understand its properties, potential applications, and mechanisms of action. This could lead to the discovery of new therapeutic approaches or the development of novel compounds with similar structures and functions.

Check Digit Verification of cas no

The CAS Registry Mumber 68422-20-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,4,2 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 68422-20:
(7*6)+(6*8)+(5*4)+(4*2)+(3*2)+(2*2)+(1*0)=128
128 % 10 = 8
So 68422-20-8 is a valid CAS Registry Number.

68422-20-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3α,16α,20(R),25-tetrahydroxy-2,11,22-trioxocucurbita-5,23(E)-diene

1.2 Other means of identification

Product number -
Other names 3-epi-isocucurbitacin D

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68422-20-8 SDS

68422-20-8Upstream product

68422-20-8Downstream Products

68422-20-8Relevant academic research and scientific papers

Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery

Hall, Jessica A.,Seedarala, Sahithi,Rice, Nichole,Kopel, Lucas,Halaweish, Fathi,Blagg, Brian S. J.

, p. 873 - 879 (2015)

Heat shock protein 90 (Hsp90) facilitates the maturation of many newly synthesized and unfolded proteins (clients) via the Hsp90 chaperone cycle, in which Hsp90 forms a heteroprotein complex and relies upon cochaperones, immunophilins, etc., for assistance in client folding. Hsp90 inhibition has emerged as a strategy for anticancer therapies due to the involvement of clients in many oncogenic pathways. Inhibition of chaperone function results in client ubiquitinylation and degradation via the proteasome, ultimately leading to tumor digression. Small molecule inhibitors perturb ATPase activity at the N-terminus and include derivatives of the natural product geldanamycin. However, N-terminal inhibition also leads to induction of the pro-survival heat shock response (HSR), in which displacement of the Hsp90-bound transcription factor, heat shock factor-1, translocates to the nucleus and induces transcription of heat shock proteins, including Hsp90. An alternative strategy for Hsp90 inhibition is disruption of the Hsp90 heteroprotein complex. Disruption of the Hsp90 heteroprotein complex is an effective strategy to prevent client maturation without induction of the HSR. Cucurbitacin D, isolated from Cucurbita texana, and 3-epi-isocucurbitacin D prevented client maturation without induction of the HSR. Cucurbitacin D also disrupted interactions between Hsp90 and two cochaperones, Cdc37 and p23.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 68422-20-8